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I.

Preface
Curiosity: inquisitive interest in others' concerns (“Merriam-Webster”). This is the word I

would use to explain my relationship with learning and academic pursuits alike. Throughout my
time at Regis, I have discovered many things about myself and learned more than I thought
possible based upon the Jesuit values that are now instilled in me. As a part of the Honors
Program, my thoughts have been challenged in more ways than one, which has pushed me to
become a better scholar, but more importantly a better person. Throughout my Jesuit education, I
have joined a cohort of people who are just as passionate about their education, but also want to
make an impact on the world. Everyone has such a unique discipline and background that allows
us to share insight from a basis of mutual respect. This Jesuit education has further enabled me to
explore a variety of subjects and double major in Neuroscience and Spanish; two subjects that I
absolutely love and have found to be surprisingly connected.
As a Spanish major, I have been driven to travel and explore the world in the context of
the language, but also medicine. Through this, my love of the language has only grown and
sparked my curiosity to its relation to the brain. Among the many advances we have made
regarding the brain, there is still so much left to discover about it! We still have so much to
explore, and that unique feature of Neuroscience is what initially piqued my interest. One of the
ideas that I pondered over as someone who is dedicated to becoming bilingual, is what does it
mean to be bilingual in the aging brain.
Although these topics are relevant to my majors and areas I have focused on a great deal,
my thesis theme originally came from personal experience. My grandfather was diagnosed with
Vascular Dementia a few years ago and watching that struggle and watching my mother work
with various healthcare providers and insurance companies and overall cope with it has really
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made me want to learn, study, and explore more about dementia. Furthermore, my grandmother
was diagnosed with dementia as well and I have noticed in my conversations with her small
changes or repeated conversations. I know I am not unique in my experience with my
grandparents and the Neurology Collaborators determined dementia to be the second leading
cause of death globally. As I continue to explore what I want to do with my life and how I can
make an impact on the world, public health has become a leading focus. Exploring the changes
that occur in the aging brain and what it means to be bilingual in different global populations
allows me to combine all my passions and interest in a meta-analysis for science going forward. I
hope at the end my readers will have a broader understanding of the value of public health and
global collaboration, the benefits associated with being bi- or multi-lingual, and the severity and
importance of dementia, specifically Alzheimer’s Disease, research.
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II.

Background
We live in a world plagued by disease and hardship, but also driven by innovation and

technology. Currently, the global burden of disease (GBD) for non-communicable diseases,
specifically neurological disorders, is on the rise and posing a challenge to the sustainability of
health care systems (GBD 2016 Neurology Collaborators, 2019; Nichols et al., 2019; Bak &
Alladi, 2014). In 2016, neurological disorders were the leading cause of disability-adjusted lifeyears (DALYs) accounting for 11.6% of global DALYs, and resulted in 16.5% of deaths globally
making it the second leading cause of death (GBD 2016 Neurology Collaborators, 2019). More
specifically, of these neurological disorders, dementias are responsible for 10.4% of neurological
DALYs (GBD 2016 Neurology Collaborators, 2019).
Dementia is a neurodegenerative disorder that results in cognitive decline (e.g., memory,
language, orientation, and judgement) and a marked deterioration in the capacity to function
independently (Atkinson, 2016; Robinson, Stephan, & Magklara, 2019). The population of
individuals with dementia is on the rise and as the global population ages and life expectancy
increases, the number of people living with dementia will also increase. The percentage of
individuals with dementia inside the population doubles nearly every five years for individuals
between 50-80 years old (Nichols et al., 2019). In 1990, there were 20.2 million people
diagnosed with dementia, but by 2016, this number had increased 117% to ~50 million. This
accounts for ~ 5% of the world elderly population (people over the age of 60) (Nichols et al.,
2019; World Health Organization, 2019; Prince et al., 2015). This trend is expected to continue
and by 2030, the number of people living with dementia is expected to be 82 million, and by
2050 it's protected to triple to 152 million (World Health Organization, 2019; Robinson,
Stephan, & Magklara, 2019).
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Dementia is a broad term and will take on many forms and versions. The most common
types of dementia include Alzheimer’s Disease (AD), Vascular Dementia, Lewy Body dementia,
and Parkinson’s Dementia (DetTure & Dickson, 2019). AD is the most common type of
dementia and is more specifically characterized by amyloid plaques and neurofibrillary tangles
(DeTure & Dickson, 2019). Like other dementias, AD is a progressive neurodegenerative
disease. It is initially characterized by memory impairment and cognitive decline, but later
impacts behavior, speech, visuospatial orientation, and the motor system (DeTure, & Dickinson,
2019).
AD can be found in individuals all over the globe. When looking at the Pacific Islands in
particular, we see that the population over the age of sixty is set to quadruple between 2014-2020
(Johnston, Preston, Strivens, Qaloewai, S., & Larkins, 2020). This will lead to a significantly
older population. A possible reason for this increase could be due to the global rise in life
expectancy. Life expectancy has steadily increased in high income countries (HICs) for decades
excluding times of war, famine, or pandemics, although there has been stagnation or decline in
groups of people who are poor or marginalized (Kontis, Bennet, Guanquan, Foreman, & Ezzati.,
2017). In a study by Kontis, Bennet, Guanquan, Foreman, & Ezzati. (2017), the researchers
looked at life expectancy projections in 35 HICs for 2030 based on a Bayesian Model. They
included countries from Asia and the Pacific, North America, central Europe and western
Europe, and Latin American countries that are members of the Organization for Economic
Cooperation and Development (OECD). What they found was that life expectancy is expected to
continue to rise and possibly reach over 90 years old for females in South Korea (Kontis, Bennet,
Guanquan, Foreman, & Ezzati, 2017). Furthermore, the life expectancy in the United States is
lower than that of other HICs and this is thought to be due to the social inequalities that exist
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inside the healthcare system (Kontis, Bennet, Guanquan, Foreman, & Ezzati, 2017). As humans
are living longer, it is important to understand what this means in regard to life expectancy, but
also how it changes health, social services, and pensions that often come after retirement (Kontis,
Bennet, Guanquan, Foreman, & Ezzati, 2017). As life expectancy increases, policies need to
change to better support aging, education, work, retirement, and social care in order to support
longer lives (Kontis, Bennet, Guanquan, Foreman, & Ezzati, 2017).
Not only is dementia one of the leading neurological disorders, it is also the leading cause
of dependency and disability worldwide (Atkinson, 2016). As previously mentioned, dementia is
characterized by the loss of independence (Robinson, Stephan, & Magklara, 2019). This loss of
independence can take a large toll on the family or caregivers in addition to a high economic toll.
In the United States, where dementia is a major health concern, the estimated health cost was
$818 million in 2015 alone (Nichols et.al, 2019). This cost is projected to increase and by 2030,
the global cost of dementia is expected to exceed 1 trillion dollars annually (Robinson, Stephan,
& Megklara, 2019). Sperling et al., (2011), found that a hypothetical delay of AD, the most
common type of dementia, by five years would lead to a 57% decrease in the number of patients
with AD. Not only would this reduce the number of AD patients, it would also decrease the
projected Medicare spending in the US for AD from $627 billion to $344 billion, nearly a 50%
cut in cost (Sperling et al., 2011; Brini et al., 2019). Similarly, a study by Bialystok, Craik, and
Freedman (2007), found that a delay of dementia by four years could translate to a 47% decrease
in the prevalence of dementia in the population. As the global population grows and dementia,
specifically AD, is on the rise, an increase in understanding the neural mechanisms behind AD
and ways to delay and slow the onset of AD are at the forefront of research. One way of doing
this is through studying the bilingual brain and how the neuroanatomical changes that occur can
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act as a defense to delay AD by upwards of five years. This paper is a meta-analysis exploring
what dementia, specifically Alzheimer’s Disease is, and what it means to be bilingual. This paper
will then further explore how we can use this information to lessen the global burden of disease
associated with AD.
III.

What is Alzheimer’s Disease

a. What we know about AD and Dementia
Dementia is characterized as a neurodegenerative disorder that leads to cognitive decline
(e.g. memory, language, orientation, and judgement) and a clear deterioration or complete loss in
the capacity to function independently (Atkinson, 2016; Robinson, Sephan, & Magklara, 2019).
The most common type of dementia, AD, is progressive, irreversible, and a disabling disease that
causes a large socioeconomic burden for communities — particularly families and individuals, as
well as the government (Crous-Bou et al., 2017). It is characterized by changes in behavior,
speech, visuospatial orientation, and changes in the motor system (DeTure & Dickson, 2019). In
the past, researchers have found that the onset of dementia and cognitive decline can be delayed
through intellectual and lifestyle factors such as high levels of education, occupation level, and
participation in leisure activities (Abutalebi et al., 2015). These factors are thought to lead to
higher levels of cognitive function and thus lower the rate of memory decline as an individual
ages. Additionally, factors such as playing an instrument, formal school, and even certain video
games are thought to improve brain fitness and reduce cognitive decline (Klein, Christie, &
Parkvall, 2016). Although these factors may appear to slow cognitive delay, there has been
increasing evidence that being bilingual has a major impact on delaying the onset of dementia
and AD as it leads to a cognitive reserve, or a maintenance of cognitive function with age
through stimulating mental and physical activity (Abutalebi et al., 2015; Atkinson, 2016; Bak &
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Alladi, 2014; Bialystok, Craik, and Freedman 2007; Bialstok, Craik, & Luk, 2012; Brini et al.,
2019; Crous-Bou et al., 2017; Klein, Christie, & Parkvall, 2016; Schwizer, Craik, & Bialstok,
2013).
Another factor in understanding dementia and AD is pre-existing conditions and/or risk
factors associated with dementia. For example, Brini et al. (2019) determined that there was not a
delayed onset in bilingual individuals who already had a Mild Cognitive Impairment (MCI), but
it did show a 3.3 year delay for dementia, and an even larger delay, 4.7 years, for AD (Brini et
al., 2019). Crous-Bou et al. (2017), also found that lifelong bilingualism is thought to delay the
onset of dementia by 4.5 years. They found it was able to do this because bilingualism
contributes to cognitive reserve and thus protects against neurodegeneration. In confirming the
delay due to bilingualism, there was no difference in the severity of the onset of dementia once it
was set in (Brini et al., 2019). These statistics suggest the importance of looking for symptoms of
cognitive impairment and tracking the changes that take place in the brain as a result of MCI’s or
other alterations in the brain. MCI’s are often seen as a precursor and early symptom of dementia
(Brini et al., 2019).
These associations found above can be linked to the risk factors — both modifiable and
nonmodifiable. Of the individuals diagnosed with dementia, 22.3% of global DALYs were
linked to high body-mass index, high fasting plasma glucose, a diet high in sugar-sweetened
beverages, and smoking (Nicols, et al, 2019). These are just a few of the manageable risk factors
associated with cognitive decline, or AD, other modifiable risk factors include depression,
mental inactivity, physical inactivity and poor diet (Crous-Bou et al., 2017). When looking at
education and smoking prevalence in a population aged fifteen and older, there was a large
evidence base for dementia risk (Nichols et al., 2019). These risks listed above are referred to as
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the manageable risk factors because they can be changed and are in our control. Furthermore,
14% of AD cases are attributed to smoking habits and 19% of AD cases globally are potentially
linked to low education (Crous-Bou et al., 2017). Schneider, Murray, Banerjee, & Mann (1999),
estimated that if there is a 10% reduction in low education in early life, for hypertension in
midlife, and for smoking and diabetes throughout the entire life, then dementia prevalence will
drop by 8.3% by 2050 and if there is a 20% reduction in these risk factors, there would be a
15.3% reduction in the global presence of dementia by 2050.
Family history plays a large role in dementia and certain biomarkers can be used to
understand dementia. In addition to the three non-modifiable risk factors of AD: old age,
genetics, and a family member previously diagnosed, the Apolipoprotein E, APOE, gene has
been linked to AD. This gene is also linked to vascular dementia, Lewy Body Dementia, Down's
Syndrome, and Traumatic Brain Injury (DeTure & Dickson, 2019). The APOE gene has three
forms, e2, e3, and e4, and can results in six possible combinations since a copy of the gene is
inherited from each parent, e2/e2, e2/e3, e2/e4, e3/e3, e3/e4 and e4/e4 (Alzheimer’s Association,
2020). Research has linked the e4 gene with an increased risk of AD as compared to e3 and e2 as
the gene with a decreased risk compared to e3. DeTure & Dickson (2019) noted that an
individual who has a single copy of the APOE4 polymorphism has an odds ratio 3x that of a noncarrier and that individuals homozygous for APOE4 have an odds ratio 12x that of non-carries.
This is important in understanding the neuropathology of AD.
Alois Alzheimer first noted the pathology for AD over 100 years ago and it is believed to
be very specific. AD is classified by the presence of amyloid plaques and neurofibrillary tangles
(DeTure & Dickson, 2019). As dense amyloid and tau positive neurites build up, they are linked
to neuronal loss and cognitive decline (DeTure & Dickson, 2019). Neuropathology of AD is
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believed to include atrophy, or shrinking, in multimodal association cortices, and limbic lobe
structures. In AD patients there is often enlarged sulcal spaces and atrophy of the gyri for the
frontal and temporal cortices (see Figure 2) (DeTure & Dickson, 2019). This makes sense when
thinking about the function of the frontal and temporal cortices as they play a role in cognitive
functioning, memory, and emotion (Gupta, 2017). If there is atrophy in these regions, then
cognitive functioning, memory, and emotion will be impacted. Furthermore, AD is linked to
atrophy in posterior cortical areas as well as in the amygdala and hippocampus.
As mentioned prior, individuals with the APOE4 gene are much more likely to develop
AD throughout their lifetime. This is because the e4 gene is more likely to have a beta-amyloid
accumulation (increased diffuse plaques, neuritic plaques, tangles, and cerebral amyloid
angiopathy) and was linked to disruption of memory function in rodents (Alzheimer’s
Association, 2020; Raber, Huang, & Ashford, 2004). If beta-amyloid is accumulated, then
microglia are likely to go through and clear out the plaques. Microglia are part of the immune
system and work to eliminate toxins and debris of dead/dying cells and when activated due to
beta-amyloid accumulation, leads to atrophy of the impacted brain areas (Alzheimer’s
Association, 2020). A study by Mayeux et al. (1998), found that 65% in 1,770 diagnosed
individuals, across 26 different Alzheimer’s Disease centers in the United States had at least one
copy of the APOE-e4 gene. Not only does the copy of genes play a role in the likelihood of
developing dementia, it is linked to the age of onset of AD. Individuals homozygous (2 copies)
of the e4 allele are much more likely to have clinical AD by the age of 66, followed by e3/e4
individuals who are likely to have an onset by the age of 73, followed by e3/e3 individuals who
are likely to have AD onset by 86 years old (Raber, Huang, & Ahsford, 2004). Individuals with
the e4 gene have more atrophy of the brain and therefore have a younger age of onset. This leads
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to variation in the age of onset based on allele combination. However, of the individuals
diagnosed with AD, 61% have the e3/e3 phenotype, 23% have the e3/e4 phenotype, and only 2%
have the e4/e4 phenotype (Raber, Huang, & Ahsford, 2004).
Socioeconomic and cultural factors are also thought to play a role in the incidence of AD.
It is suggested that certain ethnic minorities have a higher prevalence of dementia than Caucasian
individuals (Brini et al, 2019; Gurland et al., 1999). This is supported by Rajan et al (year), who
found that Black/African Americans are more likely to have at least one copy of the APOE-e4
gene compared to European Americans. Older Black/African Americans are 2x as likely to have
a dementia diagnosis than older Caucasian individuals (Alzheimer’s Association 2020). This
statistic is similar in Hispanic/Latino populations inside the United States who are 1.5 times as
likely as their caucasian counterparts to have dementia (Alzheimer’s Association. 2020).
Not only is there a higher dementia incidence in ethnic minorities, Nichols et al. (2019),
found that when age is standardized, females are 1.17 times as likely to have dementia as males.
Women also have a higher prevalence for AD and other dementia. A study found that 16% of
women over the age of 71 are diagnosed with AD while only 11% of men over the age of 71
have AD or another dementia, but this is thought to be linked to a longer life expectancy
(Alzheimer’s Association, 2020). Furthermore, the prevalence of dementia only increases with
age. Dementia is the second leading cause of death in individuals over the age of 70 and
increased 148% between 1990 and 2016. Although there are 1.17 times as many incidents of
dementia in women as there are in men, approximately every 5-5.5 years of age between 50-80,
the prevalence of dementia doubled (Nichols et al., 2019; Fiest et al., 2016). Although Nichols,
et al., standardized age, it is possible that women have a higher prevalence due to their longer life
expectancy (Fiest et. al., 2016). Fiest et al., (2016) reported that the incidence of AD dementia
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increases in both sexes until 85-90 years old at which point it plateaus for men, but continues to
increase in women.
As our population ages, dementia rises as well and the longevity of dementia is 20-30
years long and thus, the number of individuals living with dementia is thought to increase to 100152 million by 2050 (Nichols et al, 2019; World Health Organization, 2019). AD specifically is
on the rise and is projected to reach 7.1 million by 2025, a 22% increase from the 5.8 million
diagnosed in 2020 (Alzheimer’s Association, 2020). However, when looking at and
understanding the development of dementia, it is important to understand that there are three
stages to dementia: mild, moderate, and severe, and three levels of YLDs for dementia: CDR1
(mild), CDR2 (moderate), and CDR3, (severe) (Nicholes et al, 2019). Furthermore, AD has three
stages: mild, moderate, and severe. In mild AD, individuals can typically function somewhat
independently, but once they reach moderate AD, the longest phase, individuals typically lose
the ability to do simple tasks such as bathing and dressing, and by the time AD progresses to
severe AD, the individual requires constant assistance (Alzheimer’s Association, 2020). As
Alzheimer’s and other dementia progress, it is important to understand the burden of disease, but
also the disease and what it entails.
Screening for and diagnosing dementia can be done in a variety of ways. Currently
methods include a neuropsychological assessment battery, which is a comprehensive test battery
that assesses the five cognitive domains: Attention, Language, Memory, Spatial, and Executive
Functions, automated cognitive measures that comprise computerized versions of traditional or
newly developed tests, and functioning scales for daily activities (Robinson, Sephan, &
Magklara, 2019; Zgaljardic & Temple, 2010). In addition to these measures, new cognitive
instruments such as The Dementia Screening battery 100 (DES‐100, Tunisia), The NIMHANS
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Neuropsychological Battery for Elderly (NNB‐E, India), The Dementia Assessment by Rapid
Test (DART, India), The Cognitive State Test (COST, Turkey), The Identification and
Intervention for Dementia in Elderly Africans (IDEA, Sub‐Saharan Africa including Tanzania
and Nigeria) have been developed in specific LMIC countries (as listed next to the name) to take
into account cultural, literacy, and educational biases that might exist when using the HIC
screening and diagnostic methods. Furthermore, specific AD screening exists. Although the
criteria for dementia is often determined using the Diagnostic and Statistical Manual of Mental
Disorders, 5th Edition (DSM IV), AD is often determined using the National Institute on
Neurological and Communicative Disorders and Stroke and the Alzheimer Disease and Related
Disorders Association (NINCDS-ADRDA) criteria originally proposed in 1984 (Deb, Thornton,
Sambamoorthi, & Innes, 2017).
Inside the United States, there are 5.8 million individuals living with AD in 2020. This
can be broken down into three age categories: 65-74 years old (17%), 75-84 years old (47%), and
85+ years old (36%). Based on estimates, 14.7% of all people over age 70 in the United States
have some type of dementia (Hurd, Martorell, Delavande, Mullen, & Langa, 2013).
b. Financial and Familial Burden of AD
Given the longevity associated with dementia, a high financial burden falls upon families
and caregivers. This is particularly true in HICs such as the United States where the direct cost of
care for individuals with AD and related dementias was estimated to be $236 billion (Deb,
Thornton, Sambamoorthi, & Innes, 2017). This number is only set to rise and is expected to be
$1 trillion annually in the US by 2050 (Deb, Thornton, Sambamoorthi, & Innes, 2017). A similar
study by Ferri et al. (2005)., determined that 0.6% of the UK GDP goes towards taking care of
the elderly with cognitive impairment. Since dementia is the leading cause of disability and
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dependence, the financial and physical burden associated with dementia often falls on a family
member. In a study that looked at AD in particular, the researchers found that women typically
become the primary caretaker and that it is usually a daughter or wife who accepts the burden
(Alzheimer’s Association, 2020). Inside the United States, family members, friends, or other
unpaid caregivers are thought to account for 75% - 83% of caregivers (Deb, Thornton,
Sambamoorthi, & Innes, 2017; Alzheimer’s Association, 2020).
The role of caregiver takes on a physically and financially demanding responsibility.
Deb, Thornton, Sambamoorthi, and Innes (2017) found that unpaid caregivers provide
approximately 18.1 billion hours of assistance, with their care valued at $221.3 billion annually.
This type of care is known as informal. Conversely, formal care exists and involves hired
caregivers through an agency or through a direct hire individual (Hurd, Martorell, Delavande,
Mullen, & Langa, 2013). Either through formal or informal care, this is a heavy burden and
extremely costly for families. Furthermore, in 2019, the lifetime care estimate for an individual
with dementia was $357,297. This takes a toll on the family and caregivers to provide adequate
and good care. When surveyed, caregivers gave three main reasons for accepting the financial
and personal burden for a person with dementia. The first and main reason (65%) is the desire to
keep a family member or friend at home, followed by forty-eight percent who responded they
accepted in order to be close to the to the person with dementia, and finally, the caregiver felt
obligated to take care of the individual with dementia (38%) (Alzheimer’s Association, 2020).
Since many family members take on the toll of caring for an individual with dementia, it
is important to understand how to properly provide for their needs. This trend is not only
occurring in the United States. A study conducted by Giebel et al. (2019)., looked at individuals
in the UK who have dementia and the care they are given. Interestingly enough, they determined
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that the cost of informal care was relatively similar to the cost of paid care by a professional
staff. Similar to the statistics above for individuals living in the US with dementia, there are
850,000 people living with dementia in the UK and two thirds of which live in their own homes
(Giebel et al., 2019). Because of this, it is important to understand and explore the balance of
formal and informal health care especially as the population with AD and related dementia
increases.
Cost of AD and related dementias can be grouped into direct and indirect costs. There are
both direct medical, hospital visits, physician visits, emergency department visits, pharmacy, and
short term nursing facility care, and nonmedical causes, transportation, and the cost of necessary
changes such as diet or home modification (Deb, Thornton, Sambamoorthi, & Innes, 2017).
Inside the United States where there is a private healthcare system, 68% of the total direct health
care for AD and other dementia related disorders are covered by Medicare and Medicaid — our
form of public health insurance. Although Medicare and Medicaid pick up a large part of the
direct health care cost, it is estimated that patients with AD and other related dementias and their
families spend an average of $10,495 out of pocket (Deb, Thornton, Sambamoorthi, & Innes,
2017). This number increases to up to six times as much for people with AD and other related
dementias who reside in long-term care facilities or assisted living facilities (Deb, Thornton,
Sambamoorthi, & Innes, 2017). Additionally, individuals living in the community over the age
of 65 with AD and related dementias spend 44% more on health-care related costs than their
counterparts without AD or a related dementia (Deb, Thornton, Sambamoorthi, & Innes, 2017).
This is also true when looking at Medicaid spending. In AD individuals, the overall expenditure
of Medicaid was 13% higher than NonAD patients ($101,810 vs. $89,835) (Deb, Thornton,
Sambamoorthi, & Innes, 2017).

15

Additionally, when addressing the financial burden of AD, there are two typical
approaches: the “replacement cost” and “foregone wage.” The “replacement cost” takes the cost
of an equivalent service purchases in the market through a home health agency while the
“forgone wage” approaches care by looking at the value on the labor-market income foregone
because of caregiving (Hurd, Martorell, Delavande, Mullen, & Langa, 2013). However, when
using these mechanisms, it is important to address that many of the caregivers would already be
retired. Because of this, the costs were adjusted as a means to estimate the loss of income and
productive services (Hurd, Martorell, Delavande, Mullen, & Langa, 2013). With adjustments, the
estimated cost of dementia care using the “foregone wage” method was $41,689 while the value
used for the “replacement cost” method was $56,290 (Hurd, Martorell, Delavande, Mullen, &
Langa, 2013) (see Table 2 for yearly adjusted costs). This number is only set to increase total
societal costs by 80% by the year 2040 (Hurd, Martorell, Delavande, Mullen, & Langa, 2013). In
2010, the estimated monetary cost for AD alone was $172 billion however, with adjustment
Hurd, Martorell, Delavande, Mullen, & Langa (2013) predicted it to be closer to $109 billion. If
this cost is set to increase by 80% over 30 years, it becomes increasingly important to understand
and address AD and other dementias.
c. Dementia Across the Globe
Dementia impacts individuals in every part of the world. Currently Low Income
Countries (LIC) tend to have a reduced prevalence, but between 2015 and 2050, the number of
people with dementia in LIC is set to rise 264%. Similarly, in Low and Middle Income Countries
(LMIC), dementia will rise 227% in between 2015 and 2050, 223% in Middle Income Countries
(MIC), and 116% in HIC (Prince et al., 2015). Furthermore, LMIC carries the highest burden of
dementia and accounts for 58% of all global cases and this percentage is predicted to increase to
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68% of all global cases by 2050. As of 2015, East Asia has the largest population of individuals
living with dementia at 9.8 million, followed by Western Europe with 7.8 million, South Asia is
next with 5.1 million, and finally North America has 4.8 million (Prince et al., 2015). These
numbers are incredibly high and with the prediction to rise by upwards of 264%, dementia
impacts the entire globe. In Western Europe alone, the number of individuals living with
dementia is set to nearly double by 2050 and go from 7.5 million people to 14.3 million people
impacted (Prince et al., 2015). These numbers have already grown exponentially from the 2005
study by Ferri et al., where the prevalence in China/Western Pacific Countries was 6 million,
followed by Western Europe with 4.9 million, and North America with 3.4 million. Global cases
are expected to double every twenty years (Ferri et al., 2005). With global dementia cases on the
rise, and AD accounting for 60-80% of all cases, it is important to understand what these mean
for each country, the globe, and ultimately testing and preventative methods (DeTure & Dickson,
2019).
In their study, Ferri et al., (2005), used a Delphi consensus approach to look at the
prevalence of dementia from around the world. In the study, the researchers focused on dementia
prevalence in all 14 regions of the world and broke down five-year age bands for individuals
aged 60-84 and then a final group of individuals 85+ years old. The fourteen regions were based
on WHO guidelines and included AMRO [Americas], EURO [Europe], EMRO [north Africa and
the middle east], AFRO [Africa], SEARO [south Asia], and WPRO [western Pacific]). Globally,
there are roughly 4.6 million new dementia cases every year (Ferri et al., 2005). If broken down,
this is about 1 new case every 7 seconds (Ferri et al., 2005). What they determined was that
developed countries will experience a steady increase in dementia cases over the next forty years
while Latin American and African countries will have a rapid increase in the number of
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individuals living with dementia and India, China, South Asian, and Western Pacific countries
will have a rise in their already high prevalence (Ferri et al., 2005). They also predict that by
2040, the number of individuals living with dementia in North America will be the same as
individuals living with dementia in Latin America (Ferri et al., 2005). This is a staggering
increase because Latin America currently has about half as many individuals living with
dementia as North America.
To further support the points above, the prevalence of dementia increases exponentially
with age, but doubles at different rates (Schneider, Murray, Banerjee, & Mann, 1999). Dementia
doubles in 5.5 year increments of age in North America, 5.7 year increments in Asia Pacific, 5.9
year increments in Latin America, in 6.3 year increments in East Asia, in 6.5 year increments in
West and Central Europe, in 6.6 year increments in South Asia, every 6.9 years in Australasia, in
7.2 year increments in the Caribbean and SSA, and finally, in 10.6 year increments in South East
Asia (Schneider, Murray, Banerjee, & Mann, 1999).
AD rates are on the rise as well. Making up 60-80% of all dementia cases, it is estimated
that there will be 106 million cases worldwide compared to the 30 million in 2010 (Norton,
Matthews, Barnes, Yaffe, & Brayne, 2014). This is ~3.5x as many cases over 40 years. However,
many of the risks are modifiable and Norton, Matthews, Barnes, Yaffe, and Brayne (2014)
determined that combined, the seven risk factors considered account for half of the cases of AD
worldwide. The risk factors included in the study were diabetes, midlife hypertension, midlife
obesity, physical inactivity, smoking, depression and educational attainment (Norton, Matthews,
Barnes, Yaffe, & Brayne, 2014). By addressing these risk factors, by 2050 we could reduce the
worldwide prevalence of AD by 8%-15% or by 8.8 to 16.2 million cases (Norton, Matthews,
Barnes, Yaffe, & Brayne, 2014). Given that AD accounts for the largest percentage of dementia,
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reducing the prevalence by 8%-15% would significantly lower the burden associated with
dementia (see Figure 1).
d. Neuroanatomical Changes associated with AD and related dementia
A healthy adult brain will have ~100 billion neurons and create 100 trillion synapses
(Alzheimer’s Association, 2020). However, as the brain changes and ages, this can change.
Aging is a normal human process that everyone experiences. With age, the brain has both
structural and functional changes that lead to a normal amount of cognitive decline (Abutalebi et
al., 2015). As individuals age, they naturally lose grey matter in the anterior regions of the brain
and they lose white matter between the anterior and posterior cortical regions. Changes in the
brain associated with Alzheimer’s begin to take place at least 20 years before symptoms start to
appear (Alzheimer’s Association, 2020). In AD specifically, the accumulation of beta-amyloid
plaques, or beta-amyloid protein fragments, on the outside of the neuron, and accumulation of
tau tangles, an abnormal form of the protein tau, builds up inside the neuron (Alzheimer’s
Association, 2020). These changes in neuroanatomy, lead to an activation of microglia.
Microglia are responsible for clean-up of toxic proteins and dead or dying cells. Since the tau
tangles and beta-amyloid plaques are toxic changes, the microglia are activated and signaled to
go through and clear out the toxic tangles and plaques and thus, leads to atrophy, or shrinkage of
the brain (Alzheimer’s Association, 2020). Atrophy of the brain is one of the most noticeable
changes that results from AD.
White matter changes are frequently found in dementia patients. A study by Lind,
Jonsson, Karlsson, Sjögren, Wallin & Edman et al. (2006), involved participants with AD,
Frontotemporal Dementia, Vascular Dementia, and a mixture of Alzheimer’s/Vascular
Dementia. White matter consists of myelinated nerve fibers (axons) and get their color from
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myelin lipids. If myelin is reduced, it has been associated with white matter changes. Not only is
it important to look at the physical structural changes, it is also important to take into account the
personality and psychological changes that typically take place in individuals with dementia.
Behavioral changes in individuals with AD have been linked to structural changes and
degeneration in the frontotemporal lobe (Mahoney, Rohrer, Omaar, Rossor, & Warren, 2011).
AD in particular has a very specific neuropathology, but is not normally confirmed until a
post-mortem analysis. However, the pathology includes cortical atrophy throughout the brain,
but most obvious in the multimodal association cortices and the limbic lobe structures (DeTure
& Dickson, 2019). The limbic systems structures are involved in learning, memory, and emotion
(Gupta, 2017). The limbic lobe is a ring of cortex located on the medial part of the cerebral
hemisphere. The limbic lobe includes the cingulate gyrus, the parahippocampal gyrus, and septal
cortex (Gupta, 2017). Atrophy is also common in other parts of the brain. The frontal and
temporal cortices often have atrophied gyri and enlarged sulcal spaces. This is often
accompanied by medial temporal atrophy in regions of the amygdala and hippocampus — two
brain structures involved in memory and emotion (DeTure & Dickson, 2019). Not only are
temporal and frontal regions of the brain impacted, AD has two main types of lesions: amyloid
plaques and neurofibrillary tangles (Jouanne, Rault, & Voisin-Chiret, 2017). Dysfunction of the
tau and beta-amyloid proteins lead to this build up and lead to neuronal loss and cognitive
decline common in AD (Jouanne, Rault, & Voisin-Chiret, 2017; DeTure & Dickson, 2019).
IV.

What does it mean to be bilingual and how does that help us?

a. Definition
Bilingualism is a hard concept to describe because a definition can easily be too narrow
or too broad and thus leave out a large group of people or include too many. Albert Costa (2019)
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said “bilingualism is a window into the study of human cognition,” but what does this mean? A
bilingual individual processes information in two languages and has to be able to process the
different phonetic and phonological breakdowns in order to produce the correct sounds (Costa,
2019). However, bilingual studies have had varying results in whether or not being bilingual is
beneficial or harmful to an individual. The benefits are vast and thought to be greater than the
negatives associated with bilingualism. To begin, it is believed that there is joint activation of
both languages even when only speaking one language (Bialystok, Craik, & Luk, 2012). They
are thought to have better executive control and thus have outperformed monolingual
participants in naming the font color in a Stroop task, have smaller costs in task switching, and
have an increased ability to maintain a task set in an attention task (Atkinson, 2016; Bialystok,
Craik, & Luk, 2012). The Stroop Test is a commonly used neuropsychological test that assesses
the participant’s ability to inhibit cognitive inference. This is done while a specific stimulus
feature impedes the processing of a second, simultaneous stimulus (Scarpina & Tahini, 2017).
Furthermore, when looking at bilingual children, researchers found that bilingual and
monolingual children solve non-verbal tasks differently (Bialystok, Craik, & Luk, 2012). They
found that bilingual children outperformed their monolingual counterparts in non-verbal tasks,
but bilingual and monolingual children performed the same on tasks that did not include
distracting perceptual information.
Interestingly, the bilingual advantage appears to be found in older adults rather than
younger adults, but there is still an advantage for young adults on tasks that are deemed difficult
(Bialystok, Craik, & Luk, 2012). Given bilingual individuals are learning two languages at the
same time, they often have a smaller vocabulary than monolinguals. This is because bilingual
individuals are thought to be slower to comprehend and produce words. Since bilingual
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individuals are able to comprehend and process two languages, their brain has to register which
language is being spoken and respond accurately (Bialystok, Craik, & Luk, 2012). This causes
them to be more susceptible to negative priming, and this is thought to be because of greater
inhibition (Bialystok, Craik, & Luk, 2012). However an increase in the grey matter density in the
most medial part of the lobule VIIA of the right cerebellum predicted a bilingual person's ability
to resist speech interference from their first language while comprehending something in their
second language (Green & Abutalebi, 2016). This ease is something monolinguals do not have.
When looking at and defining protocol for analyzing bilingual differences, GarcíaPentón, García, Costello, Duñabeitia, & Carreiras (2016), said there needs to be a more
consistent and sophisticated method through combining behavioral and brain measures, more
complex but standardized procedures, and larger and more thoroughly characterized samples.
b. Bilingualism Across the Globe
Bialystok, Craik, and Luk, (2012) state that roughly fifty percent of the global population
is thought to be bilingual compared to twenty percent of the population in the United States and
Canada, two English speaking countries. In the past few decades there has been increased
mobility throughout European Union (EU) countries due to immigration and rapid growth in the
number of refugees (Dockrell et al., 2021). Because of this, multilingual classrooms have
become the norm where many children have different first languages. In the EU (including the
United Kingdom (UK) and Ireland), there are 23 officially recognized languages, 60 indigenous
regional and minority languages, and many non-indigenous languages spoken by migrant
communities (“Europeans and their Languages,” 2012). A long-term goal of the EU is that every
citizen has enough language skills in at least two foreign languages, but this is not yet feasible in
all countries. They found that 54% of Europeans are able to hold a conversation in at least one
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additional language, 25% could speak at least two additional languages, and 10% could speak at
least three additional languages (“Europeans and their Languages,” 2012). Over 90% of the
respondents in Luxembourg, Latvia, the Netherlands, Malta, Slovenia, Lithuania, and Sweden
speak at least two languages (“Europeans and their Languages,” 2012). Inside the EU, English is
the most widely spoken foreign language. This is interesting because the UK and Ireland were
among the countries least likely to have citizens able to speak a second language. Given that
English is considered the lingua franca, and is spoken in the United States, Canada, the UK, and
Ireland, this might be why they fall behind in bi- and multi-lingual speakers.
c. Neuroanatomical Changes associated with Bilingualism
The lifelong use of two or more languages is thought to produce neuroprotective effects
and the changes that ensue are more likely to reflect the neural response to increased demand of
neural connections in the brain (Green & Abutalebi, 2016). It is important to note that when
studying bilingualism, that it is not something that can just be reduced to structural neural
plasticity (García-Pentón, García, Costello, Duñabeitia, & Carreiras, 2016). This is because
neural plasticity does not necessarily point to a bilingual advantage (García-Pentón, García,
Costello, Duñabeitia, & Carreiras, 2016). However, the benefit of being bilingual has long been
studied with cognitive benefits detected as early as seven months old (Bak & Alladi, 2014). This
ability to detect a cognitive benefit so young has led some researchers to consider evidence that
shows that being bilingual might even be the human norm rather than the exception (Bak &
Alladi, 2014). To further explore what it means to be bilingual in the aging brain, researchers
have looked at neuroanatomical differences and the changes that take place in response to
bilingualism. Bilingualism has been linked to changes in the left inferior parietal lobe, the
anterior cingulate cortex (ACC), the dorsal ACC in particular, and the subcortical areas of the
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left caudate and putamen (Abutalebi et al., 2015; Green & Abutalebi, 2016). Aging bilinguals
have increased grey matter densities in the temporal pole and orbito-frontal complex (Abutalebi
et al., 2015). This is valuable when looking at the negative correlation often found between age
and grey matter because young bilinguals with increased grey matter maintain it throughout their
lifetime (Abutalebi et al., 2015; Green & Abutalebi, 2016).
When looking at German-French bilinguals, Chinese-English bilinguals, and SpanishEnglish bilinguals, Bialystok, Craik, and Luk (2012) found that the involvement of various brain
areas was extremely widespread in language activation. They found that when a participant
switched languages, there was distributed activation of the bilateral frontal and precentral areas,
bilateral caudate, bilateral (or midline) pre-supplementary areas (pre-SMA), and bilateral
temporal regions (Biaylstok, Craik, & Luk, 2012). This bilateral activation is particularly
interesting because it implies strong neuronal connections between both lobes of the brain. In
Japenese-English bilinguals, in particular, there was a connection between the left inferior frontal
lobe and the left middle temporal gyrus (Biaylstok, Craik, & Luk, 2012). Additionally, when
switching languages, Broca’s area which is in charge of speech production, the Dorsolateral
Prefrontal Cortex (DLPFC), and the left front area are activated (Biaylstok, Craik, & Luk, 2012).
These areas of the brain are often associated with executive control which is thought to be better
trained in bilinguals than in monolinguals (Abutalebi et al., 2015; Atkinson, 2016; Bialystok,
Craik, Luk, 2012). By processing and speaking two languages, the brain creates stronger
cognitive networks to allow for enhanced cognitive performance throughout a lifetime. This
leads to the idea of joint activation whereby bilingual speakers have some activation of both
languages when speaking (Bialystok, Craik, Luk, 2012). This connects to the idea of
bilingualism as a more holistic notion because of the different sounds and grammatical concepts

24

that in turn, lead to more executive control (Bak & Alladi, 2014) The increased executive
control portrayed by bilinguals is thought to be one of the factors that leads to the delay in the
onset of dementia. This bilingual benefit was found in frontotemporal dementia, AD, and
vascular dementia in particular (Bak & Alladi, 2014).
The cognitive benefits of bilingualism can be detected in babies as young as seven
months old (Bak & Alladi, 2014). Furthermore, the ability for babies to detect language
differences as young as seven months connects to the idea of bilingualism as a more holistic skill
due to the variety of sounds and grammatical concepts that bilingual speakers acquire (Bak &
Alladi, 2014). This varied language could lead to differences in brain region activation.
Biaylstok, Craik, & Luk, (2012) found that fMRI studies show that monolingual participants had
increased activation of the right inferior frontal gyrus whereas bilinguals have increased activity
in the left inferior frontal gyrus when measuring reaction time of switch costs.
V.

Global Burden of Disease

a. Global Health Overview: Understanding Burden of Disease
Public and Global Health professionals dedicate their life to studying and understanding
health in our local and global communities. This focus on population health allows the globe to
stay connected and follow trends and patterns between and among countries. One way to do this
is by looking at the GBD for a specific disease. The concept was first developed in the 1990s by
Harvard’s School of Public Health, the World Bank (a source of financial and technological
assistance for developing countries globally), and the World Health Organization as a way to
describe the death and loss of health as a result of injury, diseases, and other risk factors globally
(World Health Organization “Burden of disease”). The GBD is calculated by looking at the
Years of Life Lost (YLL) as a result of an early death and the number of Years of Life Lived
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with Disability (YLD) as calculated by the number of years a person lives with disability
(Whitefor, Ferrari, Degenhardt, Feigin, & Vos, 2015). These two values are then added together
to determine the Disability Adjusted Life Year (DALY), and thus the burden of disease imposed
(Chen, Jacobsen, & Deshmukh, 2015). The ability to determine the GBD for each disease in
different regions of the world is essential to improving global and community health. This
measure has been used to determine the DALY and burden of disease for more than 130 different
causes of death or disability (World Health Organization, 2019). By using data from many
countries, we can look into environmental factors and clustered risk (Nichols et al., 2019).
b. Who is most impacted?
Dementia currently impacts 50 million people worldwide (~five percent) of the elderly
population (World Health Organization, 2019; Robinson, Sephan, & Magklara, 2019). However,
of the individuals impacted, dementia disproportionately impacts individuals in LMIC and
indigenous people (Johnston, Preston, Strivens, Qaloewai, S., & Larkins, 2020). Currently, 5860% of individuals diagnosed with dementia live in LMIC, but most of the trials for dementia are
being conducted in HICs such as the United States (Johnston, Preston, Strivens, Qaloewai, and
Larkins, 2020; World Health Organization, 2019; Robinson, Sephan, & Magklara, 2019).
Furthermore, 67% of the individuals living with dementia in Africa and 63% of the individuals
living with dementia in South East Asia said their symptoms were joked about by others
(Alzheimer's Association, 2020). This stigma, along with inadequate screening causes dementia
to impact LMIC countries in particular. Screening for dementia in LMIC has been adapted from
HIC methods. Given these tools are not always adapted properly to the given country, it can lead
to education, literacy, and cultural bias (Robinson, Sephan, & Magklara, 2019). If an individual
is illiterate, it is possible that a specific battery or cognitive test will not function in the same way
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for that individual. Specifically cultural bias can appear when using HIC adapted tools to screen
indigenous groups in LMIC.
A major problem with adopting HIC screening tools is that it does not always adapt for
language and cultural norms. For example, if a culture does not follow the Western calendar,
asking someone who is taking the test what day it is would not provide fair or accurate results
(Robinson, Stephan, & Magklara, 2019). This leads to biases due to language and culture.
Furthermore, many screening tools used in LMIC countries are done to address AD and test
recall (Paddick et al., 2017). Although AD is the most prevalent dementia, screening tools need
to be more inclusive for all types of dementia. This can lead to under representation and
misrepresentation of dementia globally.
A meta-analysis by Fiest et al., (2016), looked at the prevalence of AD across 44
European, 36 Asian, 32 North American, 5 South American, 2 African, and 2 Australian studies.
When looking at the estimated age, sex, diagnostic criteria, location, and time of incidence and
prevalence, they found that there is a higher estimated prevalence of AD in North Africa than in
Asia or Europe and found a higher prevalence in North America as compared to Asia (Fiest et a.,
2016).
As previously mentioned, dementia is a growing health concern in Indigenous individuals
in particular (Johnston, Preston, Strivens, Qaloewai, S., & Larkins, 2020). In Indigenous
communities, there is limited experience and formal care. This limited diagnosis is based in the
perception of dementia in the communities. Dementia was defined in the context of aging,
mental illness, traditional cultural beliefs, and the trauma of colonization (Johnston, Preston,
Strivens, Qaloewai, S., & Larkins, 2020). Cognitive decline is perceived as a social construct that
is inevitable with aging rather than something pathological (Johnston, Preston, Strivens,
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Qaloewai, S., & Larkins, 2020). Similarly, when reviewing a study that looked at Japanese
individuals, the idea of “boke” continued to appear. “Boke” is a cultural concept that is
characterized by various signs that are typical of AD. “Boke” was defined as an individual who
is perceived to be “spacing out” or disconnected from social interactions and it is a social
responsibility to prevent “boke” (Johnston, Preston, Strivens, Qaloewai, S., & Larkins, 2020).
As individuals progress into later stages of dementia, it falls upon the family to be the
primary caregiver (Alzheimer’s Association, 2020; Kasper, Freedman, Spillman, & Wolff,
2015). In a study looking at AD, researchers found that 59% of caregivers rated their emotional
stress levels as high or very high, 30-40% reported feelings of depression, 38% indicate the
physical stress as high to very high (Alzheimer’s Association, 2020; Sallim, Sayampanathan,
Cuttilan, & Chun-Man, 2015; Collins & Kishita, 2019). These statistics further enforce the
burden of AD and the harsh reality it imposes on both the family/caregiver and the individual
diagnosed. This makes it hard to find a positive outlook on the future of dementia research, but
the narrative is changing. In an analysis of AD, the Alzheimer’s Association (2020), compared
typical age-related changes compared to signs of dementia or AD. A normal age related change
would be occasionally forgetting names or appointments, but later remembering them, but a sign
of AD or another dementia would be memory loss that disrupts life such as forgetting important
dates or events or repeatedly asking for the same information over and over again. Another
normal change in aging is developing a routine and becoming irritated when it is disrupted, but
an individual with AD or a different dementia, has a noticeable mood or personality change and
has become increasingly confused, suspicious, depressed, fearful or anxious (Alzheimer’s
Association, 2020).
c. Why is there such a large burden?
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In 2016, dementia was the leading cause of Disability Adjusted Life Years (DALYs) and
second leading cause of death for neurological disorders globally. Dementias account for 10.4%
of neurological DALYs (GBD 2016 Neurology Collaborators, 2019). Combined Neurological
Disorders are responsible for 276 million DALYs across the globe. Dementia alone accounts for
roughly 30 million DALYs for which the greatest number of DALYs due to dementia is in
individuals between the ages of 80 and 89 years old (GBD 2016 Neurology Collaborators, 2019).
When looking at noncommunicable diseases, dementia accounts for 11.9% of YLDs (World
Health Organization, 2019). These statistics cause many individuals to believe that they will
inevitably develop dementia. As the global burden of disease shifts more from communicable
(transmittable) to non-communicable diseases, it is important to be aware of the increasing
numbers and challenge to sustainable health neurological disorders in particular (World Health
Organization, 2019; Peters et al., 2019).
Another factor to take into account is the increasing life expectancy. Currently, there is a
reduced prevalence of dementia in LICs specifically due to the lower life expectancy (Prince et
al., 2015). As access to healthcare continues to grow and we transition from communicable to
non-communicable diseases as the leading causes of death, there is an increase in global life
expectancy. Although HICs still lead in life expectancy, there is an overall global increase.
Interestingly enough, the United States is behind based on its life expectancy compared to other
HICs. A study by Kontis, Bennet, Guanquan, Foreman, & Ezzati (2017), looked at 35
industrialized countries (HICs in Asia and the Pacific, North America, central Europe and
western Europe, and Latin American countries that are member of the OECD) and predicted agespecific mortality up to 2030. They found that life expectancy has steadily increased for decades
except for in times of war, famine, or infectious outbreaks in high income countries, but that this
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trend does not hold true for the marginalized groups (Kontis, Bennet, Guanquan, Foreman, &
Ezzati, 2017).
Marginalized and poor groups will not have the same access to healthy foods, healthcare,
or clean water in the same way that other, wealthier groups do and will not have the same
increase in life expectancy because there are higher levels of young adult deaths, risk for major
chronic diseases, and less effective health systems. Where social inequalities are higher, there
tends to be a lower life expectancy (Kontis, Bennet, Guanquan, Foreman, & Ezzati, 2017). This
might be the reason that the United States lags behind other high income countries. The United
States is the only OECD country without universal health care and this in turn leads to poor
healthcare due to the financial burden (Kontis, Bennet, Guanquan, Foreman, & Ezzati, 2017).
The study draws attention to the United States because they have the highest child and maternal
mortality, homicide rate, and body-mass index of any HIC (Kontis, Bennet, Guanquan, Foreman,
& Ezzati, 2017). With high and rising health inequalities, the USA’s life expectancy is set to
stagnate or even decline for certain populations (Kontis, Bennet, Guanquan, Foreman, & Ezzati,
2017).
By using the Bayesian model approach to mortality and life expectancy, life expectancy
is set to increase in all industrialized countries, particularly South Korea where the female life
expectancy is set to break 90 by 2030 (Kontis, Bennet, Guanquan, Foreman, & Ezzati, 2017).
Currently, life expectancy is lower in men because there is a greater correlation to death by
external causes such as injuries, but this gap between men and women is projected to decrease in
all of the countries except Mexico by 2030 (Kontis, Bennet, Guanquan, Foreman, & Ezzati,
2017). However, when looking at life expectancy, it is important to take into account the life
expectancy of an individual living with dementia. Inside the United States, once an individual is
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diagnosed with AD, they live an average of four to eight years, but some people live up to twenty
years with the disease (Alzheimer’s Association, 2020). The burden of AD in the US is huge,
where it is the sixth leading cause of death and the fifth leading cause of death in individuals 65
and older. In the United States alone, ~14.7% of individuals over the age of 70 have dementia
and as the population ages and individuals move into the risk category, the burden of AD and
other dementias will only increase (Hurd, Martorell, Dellavande, Mullen & Langa, 2013). In
order to combat this, the focus of preventative methods and a long term cure becomes even more
important.
When addressing the burden of AD and dementia, it is important to look at the role they
take on in LMIC countries. In LMIC countries in particular, there is a large stigma around
dementia and the symptoms that come along with it. In China, Tanzania, and India, symptoms of
dementia have traditionally been included inside the cultural conceptualization of aging
(Johnston, Preston, Strivens, Qaloewai, S., & Larkins, 2020). In China in particular, early
symptoms are believed to be a part of normal aging, but as the symptoms progress and worsen,
this often leads to social isolation of the individual with dementia. This study by Johnston,
Preston, Strivens, Qaloewai, S., & Larkins (2020) evaluated nineteen publications and of those
nineteen studies, fifteen were set in LMIC countries and three involved First Nations in Canada
and the Aboriginal Torres Strait Islander populations in Australia. A common theme they found
throughout the various communities was the belief that dementia arose as a part of natural aging
rather than as the development of a disease, or as a result from a hard life (Johnston, Preston,
Strivens, Qaloewai, S., & Larkins, 2020). Other common beliefs for dementia-like symptoms
included stress, death of a loved one, neglect by family, abuse, loneliness, various physiological
diseases, malaria, faking or deliberate misbehavior, weakness, poverty, curses, a growing
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connection with the spiritual world, colonization, witchcraft, or as a form of punishment from
your ancestors (Johnston, Preston, Strivens, Qaloewai, S., & Larkins, 2020). This false
characterization makes it hard to diagnose.
Moreover, in the First Nations Community, there has been a shift in the stigma
associated with dementia. It was once viewed as a way of being closer to the creator and the
spiritual world, but now memory loss, a common symptom of dementia, is associated with the
impact of colonization and is something to be feared (Johnston, Preston, Strivens, Qaloewai, S.,
& Larkins, 2020). As mentioned earlier with the screening techniques, low or no formal
education plays a role in bias. In addition to improving screening technique, public health
education around AD and dementia is equally as important to improving the quality of life and
presentation of the disease.
d. Solutions
AD and other dementias are debilitating and life altering diseases that we have not
figured out how to prevent or slow. In order to reduce the cost of dementia care and the burden
of disease that comes with it, there needs to be more, and better screening for earlier intervention
and more screening in high risk groups (Robinson, Sephan, & Magklara, 2019). By placing an
emphasis on these two screening practices, individuals can maintain more of a functional
independence, but also be more aware of their dementia. Currently, scientists are looking into the
benefit of playing a musical instrument, formal schooling, and even playing certain video games
on improving brain fitness and as ways to reduce cognitive decline (Klein, Christie, Parkvall,
2016). Similarly, bilingualism is thought to produce similar neural structural changes. The
increase in cognitive reserve is thought to leave indelible marks on the brain similar to those
created by highly specialized skills such as musical expertise and navigational experience (Baum
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& Titone, 2014). Additionally, they found that countries with a higher literacy had a lower
incidence of AD (Klein, Christie, Parkvall, 2016). Alzheimer’s Association (2020), determined
that brain health is closely linked to an individual's access to medical care and medical treatment.
Although researchers are still searching for a cure and successful prevention method for
dementia, they have looked into different modifiable risk factors and found ways to limit the risk
associated with modifiable risk factors.
In addition to avoiding social isolation and cognitive inactivity, there are varying levels
of recommendations. Strong recommendations for modifiable risk factors include physical
activity, stopping the use of tobacco, social interaction, and management of hypertension and
diabetes (World Health Organization, 2019; Edwards III, Gamez, Escobedo Jr., Calderon, &
Moreno-Gonzalez, 2019). Physical activity in particular is recommended for individuals to
reduce the risk of cognitive decline in people with normal cognition, but is only a conditional
recommendation in individuals who already have an MCI (World Health Organization, 2019).
Other recommendations include eating a healthy, balanced diet, eating a mediterranean-like diet,
cognitive training, interventions to reduce obesity, and management of hypertension/diabetes.
Furthermore, individuals with normal cognition or mild impairment should reduce harmful
drinking (World Health Organization, 2019; Edwards III, Gamez, Escobedo Jr., Calderon, &
Moreno-Gonzalez, 2019). However, it is important to note that The World Health Organization
does not recommend Vitamins B and E, or polyunsaturated fatty acids and multi-complex
supplementation as a way to protect cognition.
Another possible avenue of research includes drug therapy. Currently, there are five FDA
approved drugs to treat AD. These five drugs are rivastigmine, galantamine, donepezil,
memantine, and memantine combined with donepezil (Alzheimer’s Association, 2020).
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Excluding memantine, all of the drugs temporarily improve cognitive symptoms by increasing
the amount of neurotransmitter. Additionally, researchers have found that the use of
antipsychotics in individuals with dementia leads to an increased risk of stroke (Alzheimer’s
Association, 2020).
Another critical step in managing dementia is by drawing on cultural and individual
beliefs to provide the best and most holistic care. This is particularly important in LMIC
countries where more stigmas and notions exist around dementia. Dementia stigma is a major
problem and can lead to individuals being turned away from residential care or excluded from
the hospital (Ferri et al., 2005). The key to de-stigmatizing dementia is education. Many
individuals do not necessarily know they need help or if they do, will not seek out help. If a
person does seek out help, health care providers will not necessarily tend to their needs. As
prevalence increases, we need to improve medical and social care through public health
awareness and education (Ferri et al., 2005). All of these platforms involve education and to do
this we need to incorporate more in day-to-day life.
VI.

Connecting the dots between AD and Bilingualism
Various studies have looked into how bilingualism delays the onset of dementia and they

have shown that being bilingual delays the onset of dementia anywhere from 3.2 to 6 years
(Abutalebi et al., 2015; Atkinson, 2016; Bak & Alladi, 2014; Bialystok, Craik, and Freedman
2007; Brini et al., 2019; Schwizer, Craik, & Bialstok, 2013). Not only is the diagnosis of
dementia delayed in bilingual speakers, the onset of symptoms reported is an average of 5.1
years after monolingual individuals (Askinson, 2016). If the onset of dementia can be delayed by
4 years, the prevalence of dementia is reduced by 47% (Bialystok, Craik, & Freedman, 2007).
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When looking at the delay of dementia in the bilingual community, it is important to
remember how diverse of a community it is and take into account other factors such as
socioeconomic status, education level, immigration, and employment status (Bak & Alladi,
2014). When looking at these factors there have been mixed results in their role in the delayed
onset. Bialystok, Craik, and Freedman (2007), took into account cultural differences,
immigration, formal education, and employment status, but none of this could deny that being
bilingual delayed the onset. However, another study found that dementia is higher in ethnic
minorities than in Caucasian individuals suggesting that there are socioeconomic and cultural
factors that may play a role in the relationship between bilingualism and dementia (Brini et al.,
2019). Furthermore, a study that took place in Canada looked at the role of immigration in the
delayed onset of AD and the authors found that the bilingual benefit was not only seen in
immigrants, but also native born bilingual speakers (Schwizer, Craik, & Bialstok, 2013).
Although they did not see this trend in bilingual individuals whose first language was English, a
delay of 3.2 years occurred in non-immigrant bilinguals whose first language was French. They
further found that the delay of AD in the immigrant bilingual population was 5.1 years
(Schwizer, Craik, & Bialstok, 2013). This finding showed the same functional organization of
neural responses for both immigrant and nonimmigrant bilingual individuals (Schwizer, Craik, &
Bialstok, 2013). These neural responses differed from their monolingual counterparts (Schwizer,
Craik, & Bialstok, 2013). Interestingly enough, there is evidence to affirm the delay of dementia
in the bilingual brain because no differences are found between monolinguals and bilinguals on
the severity of dementia upon diagnosis (Brini et al., 2019). Had the bilingual speaker delayed
going to the doctor for cultural differences, the researchers would have expected further
cognitive decline. This suggests that being bilingual somehow better preserves the
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neurocognitive function and alters the brain so that it has enhanced cognitive function and
executive control (Atkinson, 2016).
A factor that could influence the delay in dementia onset associated with bilingualism is
the level of proficiency in each language. When choosing participants for a study involving
bilingual individuals, it is extremely important that there are clear guidelines for the definition of
bilingualism rather than a loose, liberal definition for bilingualism (Atinkson, 2016). This idea is
supported by better performance on the Stroop Test by individuals who consistently use both
languages (Atkinson, 2016; Bialystok, Craik, & Luk, 2012). Studies have found that individuals
who become bilingual during adulthood or who do not frequently speak the second language do
not have the same protection against dementia as individuals who learn a language from birth or
consistently speak both (Atkinson, 2016). The reasons behind these brain differences and what
they mean on the bilingual and aging brain are areas that are currently being studied. Discovering
the underlying mechanisms of bilingualism will provide researchers further insight into the
benefits of bilingualism for the onset of dementia. Bialystok, Crain, and Freedman (2007), said
that increased resting phosphocreatine levels,synapses and arborized dendrites, increased
generation of neurons, and functional reorganization of the brain network are among the
plausible underlying mechanisms to understanding what it means to be bilingual.
When returning to neuroanatomy, there is actually a lot of overlap between the
neuroanatomical changes that take place in a bilingual brain and in a brain with AD or a related
dementia. In bilingual individuals, there is an increase in grey matter in the temporal pole and
orbitofrontal complex (Abutalebi et al., 2015). Abutalebi et al. (2015) found this in aging
individuals in particular. This increase in grey matter creates a defense for the brain as it ages
because a common neuroanatomical change of dementia is loss of grey matter (Alzheimer’s
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Association, 2020). Furthermore, the increase in the temporal pole and orbitofrontal complex can
combat the degeneration of the frontotemporal lobe that is common of dementia, and the atrophy
of the frontal lobe and the temporal lobe that is a common trait of AD. Finally, bilingualism
leads to changes of the anterior cingulate gyrus which includes the cingulate gyrus, an area
impacted by AD. By speaking a second language, you strengthen neural connections and create a
defense to aging.
VII.

Discussion and Conclusion

a. My Opinion
After seven years of language learning in the United States I have always wanted to be
bilingual and I wish that I had learned a foreign language as a young child, rather than as a high
school student. My introduction to and love of language was not immediate and it was not until I
started college that I decided to further pursue Spanish. I am so thankful I did and hope to be a
lifelong learner of the language. Between my love of language, neuroscience, and my
grandparent’s living with dementia, this topic is very important to me.
The United States has coined the term “The Melting Pot” to refer to the various cultures,
countries, and individuals that make up our country. However, this term is also backed by a
desire to be individual and make a way for yourself. Unlike individuals I met in other countries
throughout my travels abroad, inside the US learning a second language does not begin until high
school rather than as a young child. As I discussed earlier in the text, being a lifelong learner of
the language and early development change the way the brain develops. There is even evidence
to suggest that the bilingual brain, and not the monolingual brain is the human norm (Bak &
Alladi, 2014).
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This then poses the question of “why don’t we offer language at a younger age,” but also
“why is bilingualism discouraged in the United States?.” English is the current lingua franca, but
that does not mean learning other languages is any less important. The United States is thought
to be a place to follow and achieve the “American Dream.” However, I wonder if the American
Dream might actually be perpetuating monolingualism. The United States is a very polarized
country and filled with a very racist history. I wonder if the close-mindedness of many people
inside the United States fuels the lack of language diversity and lack of empathy towards other
cultures. I know this does not apply to everyone, but a study by Bialystok, Craik, and Luk (2012)
determined that fifty percent of the world’s population is thought to be bilingual whereas only
twenty percent of the population in the United States is believed to be bilingual. This is really an
interesting statistic to reflect on given the number of people who immigrate to the US.
Furthermore in regard to dementia, 14.7% of people over the age of 70 in the US are living with
dementia and this number is only set to increase (Hurd, Martorell, Delavande, Mullen, & Langa,
2013). As more individuals move into the 65+ age group, I think as a country we need to look at
the culture we perpetuate and evaluate the mindset of the “American Dream” and instead of
driving the use of only English, we can create a more culturally accepting, and empathetic
community. Language acquisition is not an easy feat, but starting at a young age will not only
benefit our brain, but also our language skills.
In a study looking at second language acquisition in Alberta, Canada, Archibald et al.,
(2006) found that exposure to multiple languages enhances cultural awareness. When a student is
exposed to another language, they also learn about the culture and gain a respect for it. This has
great long term implications and is potentially linked to creating a more empathetic, inclusive,
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and anti-racist community (Archibald et at., 2006). Translating this practice into the United
States could prove to be extremely helpful to fostering empathy.
b. Future Implications
I reviewed studies in regard to global health and the lifetime benefit of bilingualism while
tying it all into the delay of dementia, but more specifically AD. As the general population ages,
we need to find ways to combat AD and related dementias. The research overwhelmingly points
in favor of bilingualism as a way to do this. In order for bilingualism to combat and delay the
onset of dementia, specifically AD, we need to understand the basis of bilingualism and have a
better encompassing definition. Additionally, there needs to be more access to and studies done
on a global level to analyze the number of bilingual and multilingual speakers. In my research, I
was only able to find scientific information on multilingualism in Europe. By comparing the
number of bi/multilingual speakers in Latin America, Europe, North America, Asia, Oceania,
and Africa to the number of monolingual speakers, researchers would gain insight into language
in different cultures. Furthermore, this data could then be used to look at AD prevalence and
dementia in each country as a global marker.
The brain is vital to human survival and we are constantly learning new information
about it. This makes me wonder if the term bilingual could be extended to individuals who write
and understand code. When you write in code, you are writing in a computer language. I think
this would be a really interesting avenue to explore in the future, but especially with the
Millennial and Gen Z generations as it is much more of a norm to be able to code. Additionally,
American Sign Language (ASL) is a different form of language that is widely used inside the
community. A future avenue would be to explore what neuroanatomical changes take place in
the brain structures of individuals who work with code and who speak ASL.
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Another future avenue would involve looking into bilingualism on the global scale to
understand the real presence of it. Furthermore, it would be really interesting to delve into the
role of genetics and environment in dementia development. Inside the United States,
Black/African American and Latino populations are 2x and 1.5x as likely to have a dementia
diagnosis compared to older, Caucasian adults (Alzheimer’s Association, 2020). This is a really
important statistic to explore because Stewart, Boyle, James, Yu, Han, and Bennet (2018) found
that the APOE-e4 gene had a higher prevalence in individuals with a lower financial, health, and
total literacy. APOE-e4 is a key marker of Clinical AD (Stewart, Boyle, James, Yu, Han, &
Bennet, 2018). This returns to the modifiable risk factors discussed earlier and how education
can help prevent the onset of AD. This leads me to wonder why the APOE-e4 gene is more
common in individuals with lower literacy rates. My research about the APOE-e4 gene involved
individuals in the United States. Our education system needs reform and improvement because
socioeconomic status plays a large role in the resources, funding, and the overall experience a
student has while in school. Although this is a genetic trait, I want to explore more about the role
of the environment and whether rates really are higher in lower literacy areas and if institutional
racism plays a role in the likelihood of developing AD. These are questions that we need to
explore and understand in order to progress in dementia research. Other future avenues include
looking into the mediterranean diet, whether or not being monolingual is actually a disadvantage,
and if our brains are actually designed to be bilingual. If our brains are designed to be bilingual,
this could really be a changing point in bilingual research. AD is a progressive and
neurodegenerative disease and finding ways to prevent it through limiting modifiable risks and
using language to strengthen the brain could lead to a big breakthrough in treatment, delay, and
prevention.
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Finally, as Neurological disorders are the leading cause of disability worldwide,
understanding the financial burden is extremely important. In future studies I think it would be
really valuable to look at the financial, physical, and mental toll AD and dementia take on
caregivers. I also think it would be really interesting to delve deeper into the differences between
informal and formal care.
c. Concluding Remarks and Acknowledgments
As I conclude my thesis, I am so thankful for the help and support that has been provided
along the way from my incredible honors professors, Dr. Howe and Dr. Narcisi, as well as Dr.
Fricks-Gleason my thesis advisor, and Dr. Carrión, my thesis reader. Furthermore, I want to
thank my writing group, Danielle Beckman, Lorenzo Patti, Sarah Smacgz, and Moriah Weir for
holding me accountable and providing me with much needed thesis support. Finally, I cannot
thank my friends and family for their unending support and reassurance throughout college, but
specifically my thesis process. This is not the end of the question and something I hope will
continue to be studied. Who knows, science changes every day and new advances are constantly
being made, so that in 30-40-80 years, there might be a cure to AD and dementias. My hope is
that we begin to foster more bilingual communities and education systems. As Archibaldt et al.
(2006) found, understanding and learning about another culture promotes empathy and that is
something we all could use a little bit more of in our lives.
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IX.

FIGURES AND TABLE

Figure 1. Projected Number of AD Cases Prevented, Corresponding to 10 or 20%
Reductions per Decade in Each Risk Factor. Taken from Norton, S., Matthews, F. E.,
Barnes, D. E., Yaffe, K., & Brayne, C. (2014). Potential for primary prevention of
Alzheimer's disease: an analysis of population-based data. The Lancet. Neurology,
13(8), 788–794. https://doi.org/10.1016/S1474-4422(14)70136-X
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Figure. 2 Gross Anatomy of Alzheimer’s Brain. Lateral view of an Alzheimer’s
brain can show widening of sulcal spaces and narrowing of gyri compared to a
normal brain. This may be more readily observed in coronal sections as indicated
by the arrowheads, and this atrophy is often accompanied by enlargement of the
frontal and temporal horns of the lateral ventricles as highlighted by the arrows.
Additionally, loss of pigmented neurons in the locus coeruleus is commonly
observed in the pontine tegmentum as shown with the open circle. None of these
features is exclusive to Alzheimer’s disease. Taken from DeTure, M. A., &
Dickson, D. W. (2019). The neuropathological diagnosis of Alzheimer's
disease. Molecular neurodegeneration, 14(1), 32. https://doi.org/10.1186/s13024019-0333-5
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Table 2 Yearly Cost per Person Attributed to Dementia, in 2010 Dollars. Taken from
Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013).
Monetary costs of dementia in the United States. The New England journal of medicine,
368(14), 1326–1334. https://doi.org/10.1056/NEJMsa1204629
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